In what could be termed a rare distinction, General Motors (GM) will soon have a second woman executive in its top management team when Dhivya Suryadevara takes charge as the new chief financial officer on September 1. Suryadevara had been serving as the company’s vice president of corporate finance for nearly a year. She succeeds Chuck Stevens who will be retiring next year.
Suryadevara will report to chairman and CEO Marry Barra, one among the few top-level woman executives in the American automobile industry. “Dhivya’s experience and leadership in several key roles throughout our financial operations positions her well to build on the strong business results we’ve delivered over the last several years,” said Barra.
According to the company, the new CFO was instrumental in securing a $2.2-billion SoftBank funding for its autonomous vehicle division GM Cruise last month. The other factors that make Suryadevara the ideal candidate for the post of finance chief are the pivotal role she played in the landmark acquisition of Cruise and the sale of GM’s European arm Opel, besides overseeing various expansion activities after joining the company 13 years ago.
Suryadevara had been serving as the company’s vice president of corporate finance for nearly a year
Stevens will be ending his long career with GM, spanning more than 40 years, on March 1, 2019. He had held various leadership positions in the company before being elevated to the post of CFO in January 2014. Stevens will take up an advisory role until retirement to ensure a flawless transition.
The other women executives holding senior positions in GM are EVP of global manufacturing Alicia Boler Davis and SVP of human resources Kim Brycz. Hershey (HSY) and American Water Works (AWK) are the other two major corporates having women CEOs and CFOs.
Shares of GM traded slightly higher throughout Wednesday’s regular session. The stock had jumped about 11% towards the end of May after the company secured a significant funding from SoftBank, paring most the loss they suffered since the beginning of the year.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on